By Topic

Anti-gastric cancer active immunity induced by FasL/B7-1 genes modified tumor cells

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

4 Author(s)
Shi-Ying Zheng ; Dept. of Cardio-Thoracic Surg., Suzhou Univ., Suzhou, China ; Dong Jiang ; Jun Zhao ; Jin-Feng Ge

AIM To study the activation of CTLs against gastric cancer cells induced by FasL/B7-l (FB-ll)genes modified tumor cells, and to explore whether co-expression of FasL and B7-1 in SGC-7901 tumor cells could initiate an synergistic antitumor effect. METHODS FasL and B7-1 genes were transfected into human SGC-7901 gastric cancer cells with adenovirus vectors. The positive clones were selected by G418. FasL and B7-1 were detected by Flow cytometry and RT-PCR .The abdominal infiltrating lymphocytes and sensitized spleen cells were obtained from the mice who were immunized with SGC-7901/FB-11 or wild type SGC-7901 cells intraperitoneally, and the cytotoxicity of these CTLs against tumor cells was determined by MTT assay. RESULTS Flow cytometry and RT-PCR showed that FasL and B7-1 were highly expressed. FasL+/B7-¿SGC-7901 cells (SGC-7901/FB-11) were inoculated subcutaneously in the dorsal skin of C57BL/6 mice and then they decreased their tumorigenicity greatly (p < 0.01). The SGC-7901/FB-11 cell-sensitized mice obtained the protective immune activity against the rechallenge of wild type SGC-7901 cells (p < 0.05). It was showed that the cytotoxicity of CTLs induced by SGC-7901/FB-11 cells against SGC-7901 was significantly higher than that of CTLs activated by wild-type SGC-7901 cells (p < 0.05). CONCLUSION The results suggest that the FasL and B7-1 can effectively promote the activity of CTLs against gastric cancer cells. And FasL/B7-l molecules play an important role in CTL cytotoxicity function as well. After introduced into SGC-7901 cells, Ad-B7-1 shows enhanced therapeutic efficiency for SGC-7901 cells when combined with Ad-FasL.

Published in:

BioMedical Information Engineering, 2009. FBIE 2009. International Conference on Future

Date of Conference:

13-14 Dec. 2009